CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673 | +216.0% | 57,626 | +262.9% | 0.01% | +250.0% |
| Q2 2023 | $213 | -94.2% | 15,879 | -92.9% | 0.00% | -95.6% |
| Q1 2023 | $3,683 | +480.9% | 222,178 | +551.5% | 0.04% | +400.0% |
| Q4 2022 | $634 | -99.9% | 34,105 | +2.7% | 0.01% | +80.0% |
| Q3 2022 | $426,000 | -67.7% | 33,217 | -82.3% | 0.01% | -64.3% |
| Q2 2022 | $1,318,000 | +47.1% | 188,119 | +42.1% | 0.01% | +180.0% |
| Q4 2021 | $896,000 | +409.1% | 132,366 | +296.5% | 0.01% | +400.0% |
| Q3 2021 | $176,000 | -51.5% | 33,380 | -69.3% | 0.00% | -85.7% |
| Q4 2020 | $363,000 | +57.8% | 108,714 | +117.9% | 0.01% | 0.0% |
| Q2 2020 | $230,000 | – | 49,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |